SERPING1 in Tumor Immune Microenvironment Remodeling and Malignant Progression
Advances in Clinical Medicine · 2026 · 16 (07) · 1942-1949
DOI: 10.12677/acm.2026.1672720 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical Medicine, 2026. Verfasst von 志俊 方. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
C1酯酶抑制剂(C1INH)是由SERPING1基因编码的,是补体系统经典途径和凝集素途径的重要负调节因子,也参与了接触系统、凝血和纤溶系统的调节。虽然该基因的功能缺失长期以来被认为是遗传性血管性水肿(HAE)的主要致病因素,但是近些年来,越来越多的证据表明,SERPING1在肿瘤发生发展中具有重要的生物学功能。本文对SERPING1/C1INH在肿瘤生物学中起到的多重作用做了系统的综述,主要从它抑制补体级联反应水平来重塑肿瘤免疫微环境、干预细胞内关键信号通路影响细胞存活状态、调节肿瘤相关炎症反应三个方面进行阐述。此外,根据SERPING1在各种肿瘤类型中表达的异质性以及患者预后相关性,本文对它作为生物标志物和治疗靶点的临床转化前景进行评价。C1 esterase inhibitor (C1INH), encoded by the SERPING1 gene, is a key negative regulator of the classical and lectin pathways of the complement system, and also participates in the regulation of the contact system, coagulation, and fibrinolysis. Although loss-of-function mutations of this gene have long been recognized as the major pathogenic factor of hereditary angioedema (HAE), accumulating evidence in recent years has indicated that SERPING1 plays important biological roles in tumor initiation and progression. This article provides a systematic review of the multiple roles of SERPING1/C1INH in tumor biology, primarily elaborating on three aspects: its remodeling of the tumor immune microenvironment through inhibiting the complement cascade, its intervention in key intracellular signaling pathways to influence cell survival status, and its regulation of tumor-related inflammatory responses. Furthermore, based on the heterogeneous expression of SERPING1 across various tumor types and its correlation with patient prognosis, this review evaluates its clinical translational potential as a biomarker and therapeutic target.
Zitieren
APA
方, 志. (2026). SERPING1 in Tumor Immune Microenvironment Remodeling and Malignant Progression. Advances in Clinical Medicine, 16(07), 1942-1949. https://doi.org/10.12677/acm.2026.1672720
Vancouver
方 志. SERPING1 in Tumor Immune Microenvironment Remodeling and Malignant Progression. Advances in Clinical Medicine. 2026;16(07):1942-1949. doi:10.12677/acm.2026.1672720
BibTeX
@article{2026,
author = {方, 志俊},
title = {SERPING1 in Tumor Immune Microenvironment Remodeling and Malignant Progression},
journal = {Advances in Clinical Medicine},
year = {2026},
volume = {16},
number = {07},
pages = {1942--1949},
doi = {10.12677/acm.2026.1672720}
}
EUVIMED